HEATHER STRATMANN: Open Payments
NPI 1033872734 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 49 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $275 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $262 |
| Novo Nordisk Inc | 6 | $124 |
| Lilly USA, LLC | 7 | $123 |
| Exact Sciences Corporation | 4 | $72 |
| Dexcom, Inc. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Astellas Pharma US Inc | 2 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: MOUNJARO, FARXIGA, AIRSUPRA, Wegovy, Cologuard Collection Kit, Dexcom G6 Transmitter, SPRAVATO, BREZTRI.
Industry payments across TX — which companies pay providers there.
